Charles Greg Guyer - Mar 15, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 15, 2022
Transactions value $
-$72,008
Form type
4
Date filed
3/17/2022, 09:30 PM
Previous filing
Feb 11, 2022
Next filing
May 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +11K +26.33% $0.00 53K Mar 15, 2022 Direct F1
transaction BMRN Common Stock Tax liability -$72K -920 -1.74% $78.27 52.1K Mar 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +26.5K $0.00 26.5K Mar 15, 2022 Common Stock 26.5K $78.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on March 15, 2022. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.